Instil Bio, Inc. — Director's Dealing 2022

Mar 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2022-03-04

Reporting Person: Laumas Sandeep (CFO and CBO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-04	Employee Stock Option (right to buy)	$8.62	A	234000	Acquired	2032-03-03	Common Stock (234000.0)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.